Granules India has announced that the U S Food & Drug Administration (USFDA) has granted approval for its Abbreviated New Drug Application (ANDA) for Bupropion Hydrochloride Extended-Release Tablets USP (SR) in strengths of 100 mg, 150 mg, and 200 mg.
Read More
The study focused on cancer incidence, mortality, and the quality of life for patients, noting that both India and South Africa are likely to experience a significant rise in cancer cases. In India, the increase is particularly pronounced in mouth cancers, with men frequently diagnosed with lip and mouth cancer, while breast cancer remains the most common diagnosis among women.
Read More
The National Pharmaceutical Pricing Authority (NPPA), under the Ministry of Health and Family Welfare, has announced a significant revision in the ceiling prices of essential drugs used to treat conditions such as asthma, tuberculosis (TB), and glaucoma.
Read More
In a move aimed at enhancing healthcare efficacy, Meril Life Sciences recently conducted a two-day executive program titled "Get Ahead in Life," tailored for senior and middle managers involved in healthcare supply chain management and procurement. The workshop focused on leveraging cutting-edge digital technologies, including AI, to address critical challenges and enhance the healthcare supply chain’s efficiency and transparency.
Read More
Healthcare stocks showed strong performance today, with the BSE Healthcare index rising by 235.3 points, or 0.53 per cent, to reach 44,864.03 as of 09:46 IST. The index saw notable gains across several key companies.
Read More_20240805202645_original_image_41.webp)
A 75-year-old man from Kerala was diagnosed with a rare bacterial disease called Murine Typhus on Friday, October 11. He had recently travelled to Vietnam and Cambodia, and experienced severe body pain and fatigue upon returning from his trip.
Read More
Lord’s Mark Industries has reported a robust financial performance for FY24, with revenue from operations surging by 40.41 per cent . The company's revenue increased to INR 422.24 crores, up from INR 301.08 crores in FY23, reflecting its sustained momentum in a competitive market. The company is set to go public in December 2024.
Read More
Glenmark Pharmaceuticals is recalling two products in the United States due to manufacturing issues, according to the latest report from the US Food and Drug Administration (USFDA). Glenmark Pharmaceuticals Inc., USA, the New Jersey-based subsidiary of Mumbai’s Glenmark Pharmaceuticals, has initiated recalls for Ryaltris Nasal Spray and Ciclopirox Gel.
Read More
Zantac was first approved by U.S. regulators in 1983 and quickly became the world's best-selling drug by 1988, surpassing $1 billion in annual sales. Over the years, it has been marketed by various pharmaceutical companies, including GSK, Pfizer, Sanofi, and Boehringer Ingelheim.
Read More_20240731134909_original_image_17.webp)
The digital health landscape is evolving rapidly, with a strong emphasis on technologies that enhance doctors’ productivity and improve patient care. The increasing adoption of digital tools is indicative of the healthcare sector's reliance on technology to maximize doctors' time and enhance patient care.
Read More
